Indivior Pharmaceuticals, Inc. Stock London S.E.
Stocks
INDV
US45579U1097
Pharmaceuticals
OTC Markets Traded|
Market Closed -
London S.E.
11:35:04 2025-07-24 EDT
|
5-day change | 1st Jan Change | ||
| 1,238.00 GBX | +1.56% |
|
+5.27% | +20.90% |
| Market Cap | 4.18B 3.74B 3.48B 3.16B 5.97B 405B 6B 41.83B 16.39B 206B 15.71B 15.37B 662B | P/E 2026 * |
9.63x | P/E 2027 * | 8.73x |
|---|---|---|---|---|---|
| Enterprise Value | 4.17B 3.73B 3.47B 3.15B 5.95B 404B 5.98B 41.71B 16.34B 206B 15.66B 15.32B 660B | EV / Sales 2026 * |
3.13x | EV / Sales 2027 * | 2.58x |
| Free-Float |
98.2% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Indivior Pharmaceuticals, Inc.
| 1 week | +5.27% | ||
| 1 month | +20.78% | ||
| 3 months | +60.36% | ||
| 6 months | +29.91% | ||
| Current year | +20.90% |
| 1 week | 1,160 |  | 1,264 |
| 1 month | 975.5 | | 1,264 |
| 3 years | 554.83 | | 2,020 |
| 5 years | 335 | | 2,020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.56% | +5.27% | +49.52% | -20.18% | 4.18B | |
| +0.83% | +2.56% | +39.44% | +108.64% | 1,043B | |
| +1.93% | +1.07% | +37.82% | +65.85% | 618B | |
| +1.49% | +6.36% | +19.56% | +86.50% | 481B | |
| +2.26% | +1.24% | +68.52% | +40.16% | 351B | |
| +1.45% | +2.52% | +22.83% | +44.22% | 338B | |
| +1.17% | +0.88% | +11.83% | +34.76% | 269B | |
| +0.89% | -0.28% | -6.31% | +9.65% | 244B | |
| +1.82% | +1.87% | +40.82% | +55.11% | 220B | |
| +2.77% | +2.49% | +27.84% | +102.26% | 182B | |
| Average | +1.68% | +0.28% | +31.19% | +52.70% | 416.3B | |
| Weighted average by Cap. | +1.38% | +0.60% | +32.42% | +71.20% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.33B 1.19B 1.11B 1.01B 1.9B 129B 1.91B 13.32B 5.22B 65.72B 5B 4.89B 211B | 1.4B 1.25B 1.16B 1.06B 2B 135B 2.01B 13.99B 5.48B 69.06B 5.26B 5.14B 222B |
| Net income | 474M 424M 394M 358M 677M 45.9B 680M 4.74B 1.86B 23.4B 1.78B 1.74B 75.1B | 530M 473M 440M 400M 756M 51.29B 759M 5.3B 2.08B 26.15B 1.99B 1.95B 83.92B |
| Net Debt | -12.5M -11.16M -10.39M -9.45M -17.84M -1.21B -17.91M -125M -48.97M -617M -46.94M -45.91M -1.98B | -570M -509M -474M -431M -813M -55.16B -817M -5.7B -2.23B -28.12B -2.14B -2.09B -90.25B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- INDV Stock
- INDV Stock
Select your edition
All financial news and data tailored to specific country editions
